Deal talk, drill hits and dilution: winners and losers split sharply in Week 8

• EAU Lithium (ASX:C1X) surged after it set a negotiation framework with Bolivia’s state lithium group and flagged Vulcan’s extraction technology
• Botanix (ASX:BOT) and Adherium (ASX:ADR) sank after funding announcements, as investors worried about dilution (more shares issued)
• Qube (ASX:QUB) held most of its takeover pop as the $5.20-per-share cash offer anchored the price
• Clarity Pharma (ASX:CU6) jumped on head-to-head prostate cancer imaging data that beat the current standard